What question did this study set out to answer?

This study aims to explore the role of rare disease patient advocacy groups in bridging educational gaps in Poland.

March 1, 2026Open Access

“We are ambassadors, we are advocates”: rare disease patient advocacy groups as knowledge brokers across health and social systems—a qualitative study from Poland

Key Points

This study aims to explore the role of rare disease patient advocacy groups in bridging educational gaps in Poland.
Conducted 11 qualitative interviews with leaders of Polish rare disease patient advocacy groups.
Utilized Reflexive Thematic Analysis to interpret interview data.
Followed COREQ guidelines for reporting qualitative research.
Identified four themes highlighting the roles of advocacy groups as knowledge translators.
Participants noted the importance of peer mentoring and resource provision for families.
Advocacy groups engage with professionals to co-develop educational materials.
Public awareness campaigns and collaboration with other organizations were emphasized.

Abstract

Background Rare diseases (RDs) pose a significant public health concern, particularly in Poland, where awareness among healthcare professionals, educators, and the general public remains low. Rare disease patient advocacy groups (RDPAGs), often led by caregivers, play a vital yet under recognized role in addressing these gaps through informal education and advocacy. This study explores how RDPAGs help fill systemic gaps in RD-related education. Methods This qualitative descriptive study draws on 11 interviews with leaders of Polish RDPAGs engaged in advocacy, education, and public engagement. Interviews were analysed using Reflexive Thematic Analysis, following Braun and Clarke’s six-phase framework, and reported in line with COREQ guidelines. Results The analysis identified four interrelated themes describing the educational and advocacy practices of RDPAGs. Participants portrayed RDPAGs as: (1) acting as ambassadors of knowledge across sectors by translating scientific and experiential expertise into accessible information; (2) supporting families through lived experience by providing curated resources, peer mentoring, and practical guidance, particularly following diagnosis; (3) engaging with and sometimes challenging professional expertise by sharing caregiver-informed knowledge, co-developing materials, and initiating dialogue with healthcare and education professionals; and (4) raising public awareness and engaging in policy-oriented advocacy through campaigns and inter-organizational collaboration. Collectively, participants described these practices as addressing systemic knowledge gaps and supporting cross-sectoral care navigation. Conclusion The findings indicate that healthcare, education, and policy systems in Poland already rely substantially on the informal educational and advocacy work of RDPAGs. Formal recognition and support may help stabilize these contributions, provided that issues of sustainability, role boundaries, and uneven organizational burdens are taken into account.

Bookmark

View Full Paper

Bookmark

View Full Paper

“We are ambassadors, we are advocates”: rare disease patient advocacy groups as knowledge brokers across health and social systems—a qualitative study from Poland

Key Points

Abstract

Cite This Study